Interstate Prescribing for Ketamine: Can Your Provider Be in Another State?

Interstate prescribing for ketamine follows one governing rule: your provider must hold a medical license in the state where you are physically located during the visit, not the state where the provider's office sits. This single fact determines which telehealth ketamine platforms can legally treat you, no matter how a platform markets its national reach. It also explains why some platforms serve 40 states while others serve fewer than ten, and why patients in certain states may need to look outside the major telehealth brands entirely. This guide covers state licensing requirements, DEA registration rules, and the multi-state licensing compacts reshaping interstate ketamine access in 2026.

The Core Rule: License in the Patient's State

Telehealth medical practice operates under one governing principle: a provider must be licensed in the state where the patient is located, not where the provider is sitting. This applies whether the visit happens in person or by video.

If you are in Texas and your provider is physically in New York, that provider must hold a Texas medical license, or the equivalent nurse practitioner or physician assistant license, to legally evaluate and treat you. The provider's physical location is essentially irrelevant to this requirement. This is also why telehealth ketamine platforms cannot operate in every state: they are limited to the states where their clinicians hold an active license.

DEA Registrations and Interstate Prescribing

Prescribing a controlled substance like ketamine also requires the provider to hold an active DEA registration, a federal authorization issued by the Drug Enforcement Administration that allows a provider to prescribe controlled substances from a specific registered address. A DEA registration is tied to one practice address, but it is not limited to a single state. A provider can hold one DEA registration and prescribe to patients in multiple states, as long as they also hold the appropriate medical license in each state where those patients are located.

This distinction matters: state medical licensure, not DEA registration structure, is the primary geographic constraint on telehealth ketamine access. The DEA's Diversion Control Division oversees registration requirements for controlled substance prescribers, while individual state medical boards control who may practice within their borders.

The Interstate Medical Licensure Compact (IMLC)

The Interstate Medical Licensure Compact (IMLC) is an agreement among participating states that creates an expedited licensing pathway for physicians who want to practice in multiple member states. A physician already licensed in one IMLC member state can apply for licenses in other member states through a streamlined process rather than completing each state's full application separately.

According to the Interstate Medical Licensure Compact Commission, more than 40 states now participate in the compact as of 2025. That expansion has let physician-led telehealth ketamine platforms add new states faster than they could through traditional single-state licensing alone.

Key Points About the IMLC

• The IMLC applies only to physicians, MDs and DOs. It does not cover nurse practitioners or physician assistants, who prescribe under separate compacts.
• The Nurse Licensure Compact (NLC) is a separate agreement that lets registered nurses and advanced practice registered nurses hold one multi-state license recognized across roughly 40 participating states. Many telehealth ketamine platforms use nurse practitioners as prescribers, so the NLC often governs a patient's actual access.
• The Physician Assistant Licensure Compact (PALC) is a newer, similar agreement for PAs. It covers fewer states than the IMLC or NLC so far, but membership is growing.

How This Affects Telehealth Ketamine Access

In practice, the largest telehealth ketamine platforms employ clinicians licensed across multiple states through a mix of compact frameworks and direct state-by-state licensing. That combination lets them serve patients in roughly 25-40 states without patients needing to track down where any individual provider happens to be sitting.

From a patient's perspective, what matters is not where your specific provider lives, but whether the platform has a provider licensed in your state who is accepting new patients. Our state regulations guide covers the licensing and access picture for individual states.

Platforms should be able to answer all three questions without hesitation. If a platform is vague about whether it serves your state, treat that as a reason to keep asking before you invest time in an intake appointment. Our guide to choosing a ketamine provider covers additional questions worth asking before you commit.

States Not Covered by Major Platforms

Some states are not covered by major telehealth ketamine platforms for a handful of recurring reasons:

• The platform's providers do not hold a license in that state
• State-specific regulatory requirements make the platform's operating model impractical there
• State compounding pharmacy rules limit or prevent shipping ketamine to patients in that state
• Low population density makes the market economically unviable for a national platform

Patients in an uncovered state still have options. A local in-person provider, such as an IV ketamine clinic or an in-person compounding ketamine program, exists in most states. Smaller regional telehealth practices sometimes serve states that national platforms skip. A psychiatrist may also be willing to prescribe ketamine off-label as part of a broader treatment plan, filled through a local compounding pharmacy. Our telehealth legality overview explains how state rules shape which of these options is realistic where you live.

The Future of Interstate Telehealth Prescribing

The trend in interstate telehealth prescribing is toward more flexibility, not less. State medical boards increasingly recognize that telehealth crosses state lines by design, and that a patchwork of separate licensing requirements creates real barriers to care.

The growth of licensing compacts, continued IMLC expansion, and ongoing federal policy discussion around telehealth access all point toward more standardized interstate prescribing over time. According to the U.S. Department of Health and Human Services, telehealth policy, including controlled substance prescribing rules, continues to evolve as federal agencies work toward permanent telemedicine frameworks. How that eventually interacts with state licensing requirements is still developing, and our telehealth law updates page tracks changes as they happen.

For patients today, the practical takeaway is to check your state first. If a major platform is licensed to serve your state, you likely have access to a provider regardless of where that specific clinician is physically based. If your state is not currently served, the alternatives above remain available.